Virtual Medicinal Product (VMP) - Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free

Navigation

Name Details

Name Start Date End Date
Name Current Name Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free Start Date 08-01-2007 End Date
Abbreviated Name Abbreviated Name Buprenorphine 2mg / Naloxone 500microgram SL tab sugar free Start Date 01-05-2009
Previous Abbreviated Name Buprenorphine 2mg / Naloxone 500microgram SL tablets SF Previous Start Date 08-01-2007 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 3 (CD No Register)
Route
Sublingual
Form
Sublingual tablet
Ontology Form/Route
tabletsublingual.oromucosal
Free From
Sugar-free
Name Basis
Other

Codes

ATC Code
N07BC51
BNF Start Date End Date
Current BNF 04100300 Start Date 04-04-2022 End Date
Previous BNF 04100300 Start Date 05-04-2011 End Date 03-04-2022
Previous BNF 04100000 Start Date 11-04-2007 End Date 04-04-2011
SNOMED Codes
Code Start Date End Date
11055811000001106 08-01-2007

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Buprenorphine hydrochloride Based on Base Substance Buprenorphine 2 mg
Naloxone hydrochloride dihydrate Based on Base Substance Naloxone 500 microgram

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet 2540 Part VIIIA Category C